Nuveen Fund Advisors
AZN icon

Nuveen Fund Advisors’s AstraZeneca AZN Stock Holding History

Nuveen Fund Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,520
Closed -$595K – 50
2018
Q3 		$595K Sell
7,520
-4,336
-37% -$328K 1.32% 17
2018
Q2 		$833K Sell
11,856
-3,775
-24% -$272K 1.03% 23
2018
Q1 		$1.09M Sell
15,631
-3,117
-17% -$216K 0.5% 55
2017
Q4 		$1.3M Sell
18,748
-2,800
-13% -$189K 0.38% 70
2017
Q3 		$1.46M Sell
21,548
-2,548
-11% -$161K 0.3% 107
2017
Q2 		$1.62M Sell
24,096
-4,205
-15% -$275K 0.26% 121
2017
Q1 		$1.71M Buy
28,301
+1,069
+4% +$62.2K 0.23% 151
2016
Q4 		$1.49M Buy
27,232
+9,309
+52% +$529K 0.21% 153
2016
Q3 		$1.18M Sell
17,923
-548
-3% -$35.8K 0.16% 170
2016
Q2 		$1.11M Buy
+18,471
New +$1.07M 0.17% 166

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Fund Advisors's AZN Position: Q4 2018 in Review

Nuveen Fund Advisors sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 7,520 shares — an estimated $595K sold.

Nuveen Fund Advisors first reported a position in AZN in Q2 2016 and held it in 10 quarters. The position peaked at $1.71M in Q1 2017. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

  • Nuveen Fund Advisors reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 7,520 AstraZeneca shares in Q4 2018, an estimated $595K.
  • Nuveen Fund Advisors first reported a position in AstraZeneca in Q2 2016 and held it in 10 quarters.
  • Nuveen Fund Advisors's AstraZeneca position peaked at $1.71M in Q1 2017.
  • 557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Nuveen Fund Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.